As a result, numerous oxidative stress-related molecules, such as NADPH oxidase, Nrf2, superoxide dismutase, and myeloperoxidase may be considered as the potential targets for COPD treatment. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.